Peliminary exploration on the differential diagnosis between meningioma and schwannoma using contrast-enhanced T1WI flow-sensitive black-blood sequence

Xin Cao, Kun Lv, Siting Xu, Zhe Feng, Xuyang Yin, Lei Pan, Daoying Geng, Jun ZhangFrontiers in Oncology 2023 · DOI

TL;DR

This study introduces a novel MRI technique, contrast-enhanced T1WI flow-sensitive black-blood (CE-T1WI FSBB), to differentiate between meningiomas and schwannomas. The findings reveal that schwannomas exhibit significantly more intratumoral microbleeds, suggesting a potential new imaging biomarker for preoperative diagnosis and treatment planning.

What Problem Does This Paper Address?

Accurately distinguishing between meningiomas and schwannomas before surgery is crucial for effective treatment and prognosis. While both are common benign tumors arising from the central nervous system's coverings, they can present with similar imaging characteristics, leading to diagnostic challenges. Existing MRI techniques may not always provide sufficient detail to differentiate them reliably, especially regarding subtle pathological differences that influence their biological behavior and clinical outcomes. This paper aims to address this by exploring the utility of a newly developed MRI sequence, CE-T1WI FSBB, which offers enhanced visualization of small blood vessels and microbleeds within tumors.

Methods

The researchers utilized a 3.0 T MR system with a specific CE-T1WI FSBB protocol. This sequence is designed to suppress blood flow signals, thereby improving the contrast and visualization of enhanced brain tumors and their internal structures. The key innovation lies in the application of this sequence to quantify two specific features: intratumoral vessels and intratumoral microbleeds.

To quantify these features, two neuroradiologists independently counted intratumoral vessels and microbleeds on the CE-T1WI FSBB images. They then calculated the Vessel Density Index (VDI) and Microbleed Density Index (MDI) by dividing the counts by the tumor volume. Statistical analysis, including Mann-Whitney U-tests and chi-square tests, was employed to compare these quantitative features between meningiomas and schwannomas, as well as between different subtypes of meningiomas. Inter-rater reliability was assessed using intraclass correlation coefficients (ICC).

Datasets

The study included data from 97 patients who were diagnosed with either meningioma or schwannoma via postoperative histopathology. Specifically, the dataset comprised 73 meningiomas and 24 schwannomas. The data was collected prospectively between September 2020 and April 2022.

Key Insights and Ideas

  • CE-T1WI FSBB as a Novel Diagnostic Tool: The study highlights CE-T1WI FSBB as a promising new technique for differentiating between meningiomas and schwannomas, offering a more detailed view of intratumoral vascularity and microhemorrhages.
  • Schwannomas' Predilection for Microbleeds: A significant finding is the substantially higher incidence of intratumoral microbleeds and consequently higher MDI values in schwannomas compared to meningiomas. This suggests that microhemorrhages are a more prominent feature of schwannomas.
  • Clinical Implications of Microbleeds: The presence of microbleeds in schwannomas may reflect underlying biological behavior that influences prognosis, potentially correlating with hearing loss or recurrence rates. This opens avenues for more personalized treatment strategies.
  • High Inter-Rater Reliability: The study demonstrated excellent consistency (ICC of 0.89 for vessels and 0.99 for microbleeds) between the two neuroradiologists in counting these features, validating the reliability of the CE-T1WI FSBB sequence for this purpose.
  • Subtype Differences in Meningiomas: While less pronounced than the meningioma vs. schwannoma distinction, epithelial meningiomas showed a higher incidence of microbleeds and MDI values compared to fibrous meningiomas, suggesting subtle differences even within the meningioma group.

Key Results

  • Microbleeds Differentiate Tumors: Significant differences were observed in the number of intratumoral microbleeds (P<0.01) and MDI values (P<0.01) between meningiomas and schwannomas.
  • Schwannomas Show Higher Microbleed Burden: Hemorrhagic foci were detected in 95.83% of schwannomas versus 31.50% of meningiomas.
  • No Significant Difference in Vessels or Volume: No statistically significant differences were found in the number of intratumoral vessels, VDI values, or tumor volume between meningiomas and schwannomas.
  • Excellent Consistency: The ICC for intratumoral vessel count was 0.89, and for microbleed count was 0.99, indicating excellent agreement between the two readers.
  • Epithelial vs. Fibrous Meningiomas: Epithelial meningiomas showed a higher incidence of intratumoral microbleeds (P<0.01) and MDI values (P<0.01) compared to fibrous meningiomas.

Limitations and Future Work

The authors acknowledge several limitations:

  • Lack of Gold Standard for Microbleeds: The study relied on imaging features for microbleed identification, lacking a definitive pathological gold standard for their exact number and density.
  • Limited Sample Size for Other Meningioma Subtypes: The statistical analysis was constrained by the limited number of participants in less common meningioma subtypes, preventing comprehensive comparative analysis.
  • Skull Artifacts: A notable portion of cases (16.37%) were excluded due to skull artifacts, indicating that CE-T1WI FSBB may be less effective for tumors located very close to the skull.
  • Future Directions: The authors propose future research to:
  • Add blinded radiologists to review preoperative imaging using these characteristics to assess their accuracy in differentiating meningiomas and schwannomas.
  • Expand the study to include a wider range of meningioma subtypes for more in-depth comparative analysis.
  • Further investigate the role of CE-T1WI FSBB in brain tumors, potentially exploring its application in other tumor types.

Summary updated

Abstract

CE-T<sub>1</sub>WI FSBB can be a new technique for differentiating schwannomas from meningiomas, and even different types of meningiomas. Schwannomas have a higher incidence of intratumoral hemorrhage, more intratumoral microbleeds, and higher MDI values than meningiomas, which provides a new basis for preoperative differential diagnosis and treatment decisions.
BibTeX
@inproceedings{cao2023peliminary,
  author = {Xin Cao and Kun Lv and Siting Xu and Zhe Feng and Xuyang Yin and Lei Pan and Daoying Geng and Jun Zhang},
  title = {{Peliminary exploration on the differential diagnosis between meningioma and schwannoma using contrast-enhanced T1WI flow-sensitive black-blood sequence}},
  booktitle = {Frontiers in Oncology},
  year = {2023},
  doi = {10.3389/fonc.2022.1006190},
}
Figure